解剖病理學市場規模、佔有率和成長分析（按產品/服務、應用、最終用途和地區分類）—產業預測（2026-2033 年）

全球解剖病理學市場規模預計在 2024 年達到 404.6 億美元，從 2025 年的 434.2 億美元成長到 2033 年的 762.9 億美元，在預測期（2026-2033 年）內複合年成長率為 7.3%。

全球解剖病理市場預計將迎來顯著成長，這主要得益於臨床生物標記在分子層面上對疾病的深入了解，以及臨床決策和患者預後的改善。基於生物標記的病理檢測在惡性腫瘤和新生物的診斷中的日益普及，進一步推動了這一市場需求。此外，數位顯微鏡和染色系統等先進技術在病理儀器中的應用，尤其是在印度和中國等新興市場，預計將進一步促進市場擴張。主要企業正積極研發創新病理儀器，並透過合作推出尖端產品，提升自身價值。這種領導企業間的合作環境可望加速解剖病理領域中新型解決方案的採納與應用，進而推動整體市場成長。

解剖病理學市場促進因素

由於慢性病盛行率不斷上升，以及消費者生活方式和飲食習慣的改變，解剖病理學市場預計將迎來顯著成長。老年人口，尤其是65歲及以上人群，正在迅速成長，推動了對關鍵診斷服務的需求，以應對與老齡化相關的健康問題。隨著醫療保健系統調整以提供更全面的診斷解決方案，這種人口結構的變化可能會推動組織病理學的發展。此外，大眾對慢性病的認知不斷提高，促使人們更加重視早期發現和準確診斷，從而提升了市場的整體成長潛力。

解剖病理學市場限制因素

全球翻新解剖病理設備供應有限，對解剖病理市場的成長構成重大挑戰。許多終端用戶，尤其是中小型醫院和檢查室，優先考慮成本效益高的解決方案，因此往往選擇翻新設備。然而，翻新設備的短缺限制了這些機構的取得途徑和經濟承受能力，從而構成了一大障礙。因此，翻新設備的供不應求預計將阻礙解剖病理市場的擴張和發展，影響醫療機構滿足診斷需求的能力。

解剖病理學市場趨勢

解剖病理市場正經歷顯著成長，這主要得益於數位顯微鏡、染色系統和宏觀成像技術等先進病理設備的日益普及。與傳統方法相比，這些創新提高了診斷的準確性和特異性，從而促進了其在實驗室中的廣泛應用。此外，這些先進儀器的操作簡單性也提高了病理學家和技術人員的參與度。隨著醫療機構日益重視診斷的準確性和效率，解剖病理市場預計將大幅擴張，這反映了醫療保健行業現代化和技術進步的整體趨勢。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術評估
• 監管環境
• 管道分析
• 疾病流行病學
• 專利分析

全球解剖病理學市場規模（按產品和服務分類），複合年成長率（2026-2033 年）

• 裝置
  • 玻片染色系統
  • 組織處理系統
  • 細胞處理設備
  • 切片機/冰凍切片機
  • 嵌入式系統
  • 玻璃鞋套
  • 其他產品
• 消耗品
  • 抗體
  • 一抗
  • 二抗
  • 試劑盒和試劑
  • 染色劑和溶劑
  • 固定劑
  • 其他試劑盒和試劑
  • 探測
  • 其他消耗品
• 服務
  • 組織病理學服務
  • 細胞病理服務

全球解剖病理學市場規模（按應用領域分類），複合年成長率（2026-2033 年）

• 疾病診斷
  • 癌症
  • 乳癌
  • 消化系統癌症
  • 肺癌
  • 攝護腺癌
  • 其他癌症
  • 其他疾病
• 醫學研究
• 藥物發現與開發
• 其他

全球解剖病理學市場規模（按最終用途分類）、複合年成長率（2026-2033 年）

• 醫院
• 臨床檢查室
• 診斷檢查室
• 其他

全球解剖病理學市場規模、複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• F. Hoffman-LA Roche Ltd.
• Danaher Corporation
• PHC Holdings Corporation
• Abcam Plc.
• Hologic, Inc.
• Agilent Technologies
• Becton, Dickinson And Company
• Sakura Finetek Usa Inc.
• Merck Kgaa
• Bio SB
• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Cardinal Health
• NeoGenomics Laboratories, Inc.
• BioGenex
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Siemens AG
• Cell Signaling Technology, Inc.
• PerkinElmer Inc.

結論與建議

Anatomic Pathology Market size was valued at USD 40.46 Billion in 2024 and is poised to grow from USD 43.42 Billion in 2025 to USD 76.29 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global anatomic pathology market is poised for significant growth, driven by the increasing utilization of clinical biomarkers that enhance disease understanding at a molecular level, thus improving clinical decision-making and patient outcomes. The growing prevalence of biomarker-based pathology tests aimed at malignancy and tumorigenesis further supports this demand. Additionally, the integration of advanced technologies in pathology equipment-such as digital microscopes and staining systems-especially in emerging markets like India and China, is anticipated to bolster market expansion. Key industry players are actively developing innovative pathology devices and fostering collaborations to introduce cutting-edge products, enhancing their offerings. This collaborative environment among major companies is expected to accelerate the adoption and implementation of novel solutions in anatomic pathology, fueling overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Anatomic Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Anatomic Pathology Market Segments Analysis

Global Anatomic Pathology Market is segmented by product, application, end use and region. Based on product, the market is segmented into instruments, consumables and services. Based on application, the market is segmented into disease diagnostics, medical research, drug discovery and development and others. Based on end use, the market is segmented into hospitals, clinical laboratories, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Anatomic Pathology Market

The anatomic pathology market is anticipated to experience substantial growth due to the rising prevalence of chronic diseases alongside evolving consumer lifestyles and dietary habits. The aging population, particularly individuals aged 65 and older, is rapidly increasing, creating a heightened demand for diagnostic services integral to addressing age-related health concerns. This demographic shift is likely to fuel advancements in anatomic pathology, as healthcare systems adapt to provide more comprehensive diagnostic solutions. Furthermore, as public awareness of chronic conditions grows, the market will benefit from an increased focus on early detection and accurate diagnosis, enhancing its overall growth potential.

Restraints in the Anatomic Pathology Market

The limited availability of refurbished anatomic pathology equipment globally poses a significant challenge to the growth of the anatomic pathology market. Many end users, particularly small and medium-sized hospitals and laboratories, prioritize cost-effective solutions and often opt for refurbished equipment. This preference creates a substantial barrier, as the scarcity of such equipment restricts access and affordability for these institutions. Consequently, the insufficient supply of refurbished tools is anticipated to hinder the expansion and development of the anatomic pathology market, impacting the ability of healthcare providers to equip themselves adequately for diagnostic needs.

Market Trends of the Anatomic Pathology Market

The Anatomic Pathology market is experiencing significant growth, driven by the rising adoption of advanced pathology equipment such as digital microscopes, staining systems, and gross imaging technologies. These innovations enhance diagnostic accuracy and specificity compared to traditional methods, propelling their widespread integration within laboratories. Additionally, the user-friendly nature of these advanced devices is fostering increased engagement among pathologists and laboratory technicians. As healthcare institutions prioritize precision and efficiency in diagnostics, the Anatomic Pathology market is poised for substantial expansion, reflecting a broader trend towards modernization and technological advancement within the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree Of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis
• Disease Epidemiology
• Patent Analysis

Global Anatomic Pathology Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Instruments
  • Slide Staining Systems
  • Tissue Processing Systems
  • Cell Processors
  • Microtomes & Cryostat
  • Embedding Systems
  • Cover Slippers
  • Other Products
• Consumables
  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Kits And Reagents
  • Stains And Solvents
  • Fixatives
  • Other Kits and Reagents
  • Probes
  • Other Consumables
• Services
  • Histopathology Services
  • Cytopathology Services

Global Anatomic Pathology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Diagnostics
  • Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers
  • Other Diseases
• Medical Research
• Drug Discovery and Development
• Others

Global Anatomic Pathology Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinical Laboratories
• Diagnostic Laboratories
• Others

Global Anatomic Pathology Market Size & CAGR (2026-2033)

• North America (Product & Services, Application, End Use)
  • US
  • Canada
• Europe (Product & Services, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffman-LA Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson And Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek Usa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Kgaa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations